For musculoskeletal disorders, arthralgia is another remarkable finding that PD-1 or PD-L1 inhibitors had a higher risk compared with control groups (RR: 1.27, 95% CI: 1.10–1.47) and the forest plot was shown in Figure 4. This evidence concerns the gene RPL17 and musculoskeletal system disorder.